| |
---|
| Detailed Price Information Link |
BACTERIA | How to read the following data (Example) |
Name: | Streptomyces ambofaciens Pinnert-Sindico 1954 emend. Nouioui et al. 2018 |
DSM No.: | 40053, Type strain dsm-40053 dsm40053 dsm 40053 Streptomyces ambofaciens |
Other collection no. or WDCM no.: | ATCC 23877,CBS 616.68,IFO 12836,ISP 5053,JCM 4204,RIA 1115,NBRC 12836 |
Isolated from: | soil |
Country: | France |
Date of sampling: | before 22.08.1990 |
Nagoya Protocol Restrictions: | France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de |
History: | <- E.B. Shirling, ISP <- R. Despois, 3486 |
Genbank accession numbers: | 16S rRNA gene: CP012382 16S rRNA gene: 16S rRNA gene: AB184182 |
Cultivation conditions: | Medium 65 , 28°C or Medium 84 , 28°C
Complete DSMZ Media List |
Summary and additional information: | <- E.B. Shirling, ISP <- R. Despois, 3486. Soil; France. Type strain. Taxonomy/description (1300). Produces spiramycin netropsin (= congocidin), spiramycin I, II, III. Strain-specific literature (3845). (Medium 65, 28°C). |
Wink compendium: | DSM 40053.pdf |
Literature: | 1300, 3845 |
Image: | ###IMAGE_TPL### Medium 65 28°C © Leibniz-Institut DSMZ |
Risk group: | 1 (classification according to German TRBA) |
Supplied as: | Delivery form | | Prices | | Freeze Dried | | 100,- € | Active culture on request | | 240,- € | DNA | | 150,- € | | Price Category for this culture: 1 |
Freight and handling charges will be added. See price list. |
Other cultures: | All DSMZ cultures of the species |
| Print data sheet |